FERTIN

What this means for you

Not registered yet, but its 29 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98065183

Mark type

Stylized text

Filed

29 Jun 2023

Published for opposition

10 Dec 2024

Attorney of record

Tamar Niv Bessinger

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for smoking cessation; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of insomnia and sleep disorders, and to improve quality and quantity of sleep; pharmaceutical preparations to treat fever; pharmaceutical preparations to treat inflammation; Pharmaceutical preparations for the treatment of arthritis; psychotherapeutic pharmaceutical preparations; pharmaceutical preparations for treatment of cold; Pharmaceutical preparations for treatment of flu; Pharmaceutical preparations for treatment of cough; Pharmaceutical preparations for treatment of sinus; Pharmaceutical preparations for treatment of allergy; Pharmaceutical preparations for treatment of cardiovascular diseases; Pharmaceutical preparations for treatment of neurological disorders; Pharmaceutical preparations for treatment of chronic pain; Pharmaceutical preparations for treatment of gastro-intestinal disorders; vitamins; dietary supplements prepared from fruit extracts; dietary supplements prepared from vegetable extracts; dietary supplements prepared from herbal extracts; dietetic supplements prepared from herbal extracts; dietetic supplements prepared from fruit extracts; dietetic supplements prepared from vegetable extracts; nicotine chewing gum for use as aid to stop smoking; medicated chewing gum; dietetic substances adapted for medical use; herbal extracts for medical purposes; herbal teas for medicinal purposes
• Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals and nutraceuticals; consultancy regarding the custom manufacture of pharmaceuticals and nutraceuticals; provision of advice, information and consultancy in relation to the aforesaid services
• Class 042 — Scientific and technological services: Research and development of technology in the field of smoking cessation preparations; research and development of technology in the field of analgesics; research and development of technology in the field of sleep aid drugs; research and development of technology in the field of anti-pyretic drugs; research and development of technology in the field of anti-inflammatory preparations; research and development of technology in the field of pharmaceutical preparations for the treatment of arthritis; research and development of technology in the field of psychotherapeutic preparations; research and development of technology in the field of pharmaceutical preparations for treatment of cold; research and development of technology in the field of pharmaceutical preparations for treatment of flu; research and development of technology in the field of pharmaceutical preparations for treatment of cough; research and development of technology in the field of pharmaceutical preparations for treatment of sinus; research and development of technology in the field of pharmaceutical preparations for treatment of allergy; research and development of technology in the field of pharmaceutical preparations for treatment of cardiovascular diseases; research and development of technology in the field of pharmaceutical preparations for treatment of neurological disorders; research and development of technology in the field of pharmaceutical preparations for treatment of chronic pain; research and development of technology in the field of pharmaceutical preparations for treatment of gastro-intestinal disorders; design of new products for others; scientific and technological services in the nature of testing of new products for others; medical research services; scientific research services; pharmaceutical products development; formulation of inhaled therapeutics; research and development of inhaled therapeutics; formulation of pharmaceuticals for oral and intra-oral delivery systems; research and development of pharmaceuticals for oral and intra-oral delivery systems

Owner

• Fertin Pharma A/S, Vejle, DK
• Fertin Pharma A/S, Vejle, DK

Prosecution history

• 29 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 28 Jan 2026 — SOU EXTENSION 2 GRANTED
• 28 Jan 2026 — SOU EXTENSION 2 FILED
• 28 Jan 2026 — SOU TEAS EXTENSION RECEIVED
• 26 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 25 Jul 2025 — SOU EXTENSION 1 GRANTED
• 25 Jul 2025 — SOU EXTENSION 1 FILED
• 25 Jul 2025 — SOU TEAS EXTENSION RECEIVED
• 04 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 10 Dec 2024 — PUBLISHED FOR OPPOSITION
• 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 14 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 14 Nov 2024 — EXAMINER'S AMENDMENT ENTERED
• 14 Nov 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED